SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-18-169675
Filing Date
2018-05-21
Accepted
2018-05-21 16:53:02
Documents
2
Group Members
EDWIN M. KANIA, JR.FLAGSHIP V VENTURELABS RX FUND, L.P.FLAGSHIP VENTURELABS IV LLCFLAGSHIP VENTURELABS V LLCFLAGSHIP VENTURES FUND IV GENERAL PARTNER LLCFLAGSHIP VENTURES FUND IV, L.P.FLAGSHIP VENTURES FUND IV-RX, L.P.FLAGSHIP VENTURES FUND V GENERAL PART

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D d574695dsc13d.htm SC 13D 244651
2 EX-99.1 d574695dex991.htm EX-99.1 17704
  Complete submission text file 0001193125-18-169675.txt   264553
Mailing Address ONE MEMORIAL DRIVE, 7TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MEMORIAL DRIVE, 7TH FLOOR CAMBRIDGE MA 02142 617-868-1888
Flagship Ventures Fund V, L.P. (Filed by) CIK: 0001627639 (see all company filings)

IRS No.: 611749444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 620 MEMORIAL DRIVE SUITE 200 WEST CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 200 WEST CAMBRIDGE MA 02139 617 870 8281
Evelo Biosciences, Inc. (Subject) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90477 | Film No.: 18850257
SIC: 2834 Pharmaceutical Preparations